176 A Randomized Controlled Trial of Rsv Prophylaxis with Motavizumab Vs Palivizumab in Young Children with Hemodynamically Significant Congenital Heart Disease
2017 ◽
Vol 70
(16)
◽
pp. C165
◽
2020 ◽
Vol 34
(6)
◽
pp. 1550-1555
◽